{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [
    [
      "MHC-I",
      "NLRC5",
      "cancer immunotherapy"
    ]
  ],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "33671123",
  "DateCompleted": {
    "Year": "2021",
    "Month": "04",
    "Day": "13"
  },
  "DateRevised": {
    "Year": "2021",
    "Month": "04",
    "Day": "13"
  },
  "Article": {
    "ArticleDate": [
      {
        "Year": "2021",
        "Month": "02",
        "Day": "17"
      }
    ],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "1964",
      "10.3390/ijms22041964"
    ],
    "Journal": {
      "ISSN": "1422-0067",
      "JournalIssue": {
        "Volume": "22",
        "Issue": "4",
        "PubDate": {
          "Year": "2021",
          "Month": "Feb",
          "Day": "17"
        }
      },
      "Title": "International journal of molecular sciences",
      "ISOAbbreviation": "Int J Mol Sci"
    },
    "ArticleTitle": "The MHC Class-I Transactivator NLRC5: Implications to Cancer Immunology and Potential Applications to Cancer Immunotherapy.",
    "Abstract": {
      "AbstractText": [
        "The immune system constantly monitors the emergence of cancerous cells and eliminates them. CD8<sup>+</sup> cytotoxic T lymphocytes (CTLs), which kill tumor cells and provide antitumor immunity, select their targets by recognizing tumor antigenic peptides presented by MHC class-I (MHC-I) molecules. Cancer cells circumvent immune surveillance using diverse strategies. A key mechanism of cancer immune evasion is downregulation of MHC-I and key proteins of the antigen processing and presentation machinery (APM). Even though impaired MHC-I expression in cancers is well-known, reversing the MHC-I defects remains the least advanced area of tumor immunology. The discoveries that NLRC5 is the key transcriptional activator of MHC-I and APM genes, and genetic lesions and epigenetic modifications of <i>NLRC5</i> are the most common cause of MHC-I defects in cancers, have raised the hopes for restoring MHC-I expression. Here, we provide an overview of cancer immunity mediated by CD8<sup>+</sup> T cells and the functions of NLRC5 in MHC-I antigen presentation pathways. We describe the impressive advances made in understanding the regulation of NLRC5 expression, the data supporting the antitumor functions of NLRC5 and a few reports that argue for a pro-tumorigenic role. Finally, we explore the possible avenues of exploiting NLRC5 for cancer immunotherapy."
      ]
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Immunology and Cell Biology, Faculty of Medicine and Health Sciences, Universit\u00e9 de Sherbrooke, Sherbrooke, QC J1H 5N4, Canada."
          }
        ],
        "LastName": "Shukla",
        "ForeName": "Akhil",
        "Initials": "A"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Immunology and Cell Biology, Faculty of Medicine and Health Sciences, Universit\u00e9 de Sherbrooke, Sherbrooke, QC J1H 5N4, Canada."
          }
        ],
        "LastName": "Cloutier",
        "ForeName": "Maryse",
        "Initials": "M"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Immunology and Cell Biology, Faculty of Medicine and Health Sciences, Universit\u00e9 de Sherbrooke, Sherbrooke, QC J1H 5N4, Canada."
          }
        ],
        "LastName": "Appiya Santharam",
        "ForeName": "Madanraj",
        "Initials": "M"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Immunology and Cell Biology, Faculty of Medicine and Health Sciences, Universit\u00e9 de Sherbrooke, Sherbrooke, QC J1H 5N4, Canada."
          },
          {
            "Identifier": [],
            "Affiliation": "CRCHUS, Centre Hospitalier de l'Universit\u00e9 de Sherbrooke, Sherbrooke, QC J1H5N4, Canada."
          }
        ],
        "LastName": "Ramanathan",
        "ForeName": "Sheela",
        "Initials": "S"
      },
      {
        "Identifier": [
          "0000-0002-7563-576X"
        ],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Immunology and Cell Biology, Faculty of Medicine and Health Sciences, Universit\u00e9 de Sherbrooke, Sherbrooke, QC J1H 5N4, Canada."
          },
          {
            "Identifier": [],
            "Affiliation": "CRCHUS, Centre Hospitalier de l'Universit\u00e9 de Sherbrooke, Sherbrooke, QC J1H5N4, Canada."
          }
        ],
        "LastName": "Ilangumaran",
        "ForeName": "Subburaj",
        "Initials": "S"
      }
    ],
    "GrantList": [
      {
        "GrantID": "PJT-153174",
        "Acronym": "CAPMC",
        "Agency": " CIHR",
        "Country": "Canada"
      }
    ],
    "PublicationTypeList": [
      "Journal Article",
      "Review"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "Switzerland",
    "MedlineTA": "Int J Mol Sci",
    "NlmUniqueID": "101092791",
    "ISSNLinking": "1422-0067"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Antigens, Neoplasm"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Intracellular Signaling Peptides and Proteins"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Trans-Activators"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [],
      "DescriptorName": "Animals"
    },
    {
      "QualifierName": [
        "metabolism"
      ],
      "DescriptorName": "Antigens, Neoplasm"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Genes, MHC Class I"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Immunotherapy"
    },
    {
      "QualifierName": [
        "metabolism"
      ],
      "DescriptorName": "Intracellular Signaling Peptides and Proteins"
    },
    {
      "QualifierName": [
        "immunology",
        "therapy"
      ],
      "DescriptorName": "Neoplasms"
    },
    {
      "QualifierName": [
        "metabolism"
      ],
      "DescriptorName": "Trans-Activators"
    }
  ],
  "CoiStatement": "The authors declare no conflict of interest."
}